skip to main content

H.R. 467: Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021


We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Jan 25, 2021.


Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021

This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.